As described in the Misuse of Drugs Act 1971 and the Misuse of Drugs Regulations (MDR) 2001, any company wishing to possess, manufacture, produce or supply controlled drugs in England, Wales or Scotland will need to apply for a domestic licence – this includes where you are not physically handling but are directing and / or taking ownership.
FSN (Field Safety Notice) for Zoll Powerheart G5 AEDs was issued by Zoll earlier this year for G5 AEDs that may display Error Code (EC) 501.
It is common in today’s rapidly evolving pharmaceutical sector that companies need to outsource key activities. This can be for a number of reasons including specialist expertise, specialist storage facilities, capacity of both facilities and people, cost to your organisation and time.
The market entry process for distance selling pharmacies is closing on 23rd June 2025. Having been laid before parliament on the 2nd of June changes to the community pharmacy sector will come into force in 21 days.
It is common in today’s rapidly evolving pharmaceutical sector that companies need to outsource key activities. This can be for several reasons including specialist expertise, specialist storage facilities, capacity of both facilities and people, cost to your organisation and time.
GDP certificates are not being automatically extended to the end of 2025 if they are approaching their expiry or have already expired.
Following a government consultation, updated guidance on the application and implications of Intellectual Property (IP) restrictions has been published. Essentially there is no change to the rules that were established following Brexit, but it is important for businesses who participate in this trading style are aware of the rules.
The MHRA continue to scrutinise and take action against Pharmacies and Clinics who are promoting Prescription Only Medicines (POMs) to the public. However, this month’s advertising investigations bulletin also includes action against a journalist newspaper article.
The Responsible Person for Import (RPi) is an important role to maintain oversight of the supply chain of medicines imported for use in the UK.
